Orphan Products

View: All  |  A  |  B  |  F  |  G  |  L  |  S  |  U  

A
show more Abelcet
Amphotericin Lipid Complex

Therapeutic Area: Antibiotics/Anti-Infectives
Sponsored By: Orphan Australia

Product Information for Abelcet Consumer Medicine Information for Abelcet

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

Abelcet is indicated for the treatment of invasive fungal disease caused by organisms susceptible to amphotericin B

show more Actiq
fentanyl citrate

Therapeutic Area: Oncology
Sponsored By: Orphan Australia

Product Information for Actiq Consumer Medicine Information for Actiq

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

Actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

show more Antabuse
disulfiram

Therapeutic Area: Psychiatry
Sponsored By: Orphan Australia

Product Information for Antabuse Consumer Medicine Information for Antabuse

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

ANTABUSE Tablets are indicated to act as a deterrent to alcohol consumption and an aid in the overall management of selected chronic alcoholic patients involved in an integrated programme of counselling and psychiatry. Only alcoholic patients who are motivated to abstain from drinking and who are undergoing supportive psychotherapeutic treatment, ancillary to a total programme of rehabilitation, should be selected for ANTABUSE administration.

B
show more Busulfex
busulfan

Therapeutic Area: Immunosuppressants
Sponsored By: Orphan Australia

Product Information for Busulfex Consumer Medicine Information for Busulfex

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

Busulfex is indicated for use in combination with cyclophosphamide, melphalan or fludarabine in conditioning prior to haematopoietic stem cell transplantation.

F
show more Ferriprox Oral Solution
deferiprone

Therapeutic Area: Haematology
Sponsored By: Orphan Australia

Gluten Free
Lactose Free
Product Information for Ferriprox Oral Solution Consumer Medicine Information for Ferriprox Oral Solution
Gluten Free
Lactose Free

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

FERRIPROX is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine or in whom desferrioxamine therapy has proven ineffective.

show more Ferriprox tablets
deferiprone

Therapeutic Area: Haematology
Sponsored By: Orphan Australia

Gluten Free
Lactose Free
Product Information for Ferriprox tablets Consumer Medicine Information for Ferriprox tablets
Gluten Free
Lactose Free

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

FERRIPROX is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine or in whom desferrioxamine therapy has proven ineffective.

G
show more Gabitril
tiagabine hydrochloride monohydrate

Therapeutic Area: Neurology
Sponsored By: Orphan Australia

Product Information for Gabitril Consumer Medicine Information for Gabitril

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

For the treatment of partial seizures, as add on therapy in patients who are not controlled satisfactorily with other antiepileptic drug(s).

show more Gelclair
sodium hyaluronate

Therapeutic Area: Pain
Sponsored By: Orphan Australia

Product Information for Gelclair

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

Gelclair is a viscous oral gel for the management and relief of pain associated with oral lesions, particularly oral mucositis/stomatitis, which may be caused by chemotherapy or radiation therapy and irritation from oral surgery. Gelclair forms a protective coating over the oral mucosa which shields exposed or sensitised nerve endings from over-stimulation and provides oral pain relief. It does not irritate or sting and is non-numbing.

show more Gliadel
carmustine

Therapeutic Area: Oncology
Sponsored By: Orphan Australia

Product Information for Gliadel Consumer Medicine Information for Gliadel

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

Gliadel is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation. GLIADEL is also indicated for use as adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme (GBM) for whom surgical resection is indicated.

L
show more Litak
cladribine

Therapeutic Area: Oncology
Sponsored By: Orphan Australia

Product Information for Litak Consumer Medicine Information for Litak

Medical Queries: 02 8436 8300


Please contact your doctor or healthcare professional if you have any questions about your medical condition or its treatment. Aspen does not provide medical advice to patients or consumers. For Aspen prescription products you will find information about your medicine in the Consumer Medicine Information sheet available on this website.

Main Indication:

LITAK is indicated for the treatment of hairy cell leukaemia and the second line treatment of lymphoplasmacytic lymphoma (Waldenstro╠łm’s Macroglobulinaemia), i.e. after failure of alkylating agents.